Immunology and Microbiology
Adoptive Immunotherapy
85%
T Cell
76%
Interleukin 2
38%
Cancer Cell
38%
Chimeric Antigen Receptor
38%
T-Cell Signaling
28%
CD28
28%
Natural Killer Cell
28%
Cytokine Release
23%
Antineoplastic Activity
23%
Cell Surface
19%
Sensitization
19%
Myeloid
19%
Cancer Immunotherapy
19%
Integrin
19%
Immunological Memory
9%
Germ Cell
9%
Tumor Volume
9%
Chimeric Antigen Receptor T-Cell
9%
Myeloid-Derived Suppressor Cell
9%
Regulatory T Cell
9%
Prostaglandin E2
9%
Immunotherapy
9%
Prostaglandin E
9%
Co-Stimulation
9%
Tumor Vascularization
9%
Upregulation
9%
Ligand Binding Domain
9%
Preclinical Study
9%
Medicine and Dentistry
Chimeric Antigen Receptor
66%
Solid Malignant Neoplasm
47%
Chimeric Antigen Receptor T-Cell
47%
T Cell
47%
Neoplasm
33%
Chimeric Antigen Receptor T-Cell Immunotherapy
28%
Krukenberg Tumor
28%
T-Cell Signaling
28%
Ovarian Cancer
28%
Cancer Immunotherapy
28%
Malignant Neoplasm
19%
Hematologic Malignancy
14%
Receptor
14%
CD3 Antigen
14%
Co-Stimulation
9%
Xenograft
9%
Cell Surface
9%
Clinical Stage
9%
Chimeric Protein
9%
Biogenesis
9%
Long Term Survival
9%
Transcriptomics
9%
Folate Receptor
9%
Natural Killer Cell Receptor NKG2D
9%
Human Leukocyte Antigen
9%
ErbB
9%
Cancer
9%
Tumor Antigen
9%
Mesothelin
9%
Immunosuppressive Drug
9%
Oxidative Phosphorylation
9%
Diseases
9%
Biochemistry, Genetics and Molecular Biology
T Cell
100%
Chimeric Antigen Receptor
57%
Cancer Immunotherapy
47%
Interleukin 2
38%
Signal Transduction
28%
CD28
28%
NKG2D
28%
Antineoplastic Activity
23%
Cytokine Release
23%
Cancer Cell
19%
Integrin
19%
Cytarabine
19%
Myeloid
19%
Sensitization
19%
Prostaglandin E2 Receptor
9%
Prostaglandin E
9%
